Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-07 06:01 am Sale | 2026-05-04 | 13D | GYRE THERAPEUTICS INC GYRE | Songjiang Ma | 7,342,131 6.330% | -114,716 (-1.54%) | Filing History |
| 2026-05-06 9:53 pm Purchase | 2026-05-04 | 13D | GYRE THERAPEUTICS INC GYRE | Luo Ying | 10,211,387 8.600% | 1,752,404 (+20.72%) | Filing History |
| 2026-05-06 8:46 pm Purchase | 2026-05-04 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 86,323,015 69.100% | 13,009,130 (+17.74%) | Filing History |
| 2024-09-06 08:31 am Purchase | 2024-09-06 | 13D | GYRE THERAPEUTICS INC GYRE | Songjiang Ma | 7,456,847 7.620% | 7,456,847 (New Position) | Filing History |
| 2024-09-06 08:15 am Purchase | 2024-09-06 | 13D | GYRE THERAPEUTICS INC GYRE | Luo Ying | 8,458,983 8.540% | 8,458,983 (New Position) | Filing History |
| 2024-02-14 1:18 pm Sale | 2023-12-31 | 13G | GYRE THERAPEUTICS INC GYRE | LYTTON LAURENCE W | 0 0.000% | -2,667,333 (Position Closed) | Filing History |
| 2024-01-24 5:11 pm Unchanged | 2024-01-22 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.340% | 0 (Unchanged) | Filing History |
| 2023-11-27 4:49 pm Unchanged | 2023-11-22 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.360% | 0 (Unchanged) | Filing History |
| 2023-11-01 4:58 pm Purchase | 2023-10-30 | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.360% | 67,047,364 (+1069.93%) | Filing History |
| 2023-10-30 7:28 pm Unchanged | 2023-10-27 | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 62,665 16.500% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | CATALYST BIOSCIENCES INC N CBIO | Nantahala Capital Management, LLC | 4,381 1.400% | -23,236 (-84.14%) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | CATALYST BIOSCIENCES INC N CBIO | ORBIMED ADVISORS LLC | 0 0.000% | -13,506 (Position Closed) | Filing History |
| 2023-02-13 2:55 pm Purchase | 2022-12-31 | 13G | CATALYST BIOSCIENCES INC N CBIO | LYTTON LAURENCE W | 26,673 7.100% | 8,032 (+43.09%) | Filing History |
| 2023-02-13 12:06 pm Sale | 2022-12-30 | 13G | CATALYST BIOSCIENCES INC N CBIO | Renaissance Technologies LLC | 11,870 3.140% | -5,849 (-33.01%) | Filing History |
| 2023-01-04 6:13 pm Purchase | 2022-12-26 | 13D | CATALYST BIOSCIENCES INC N CBIO | GNI Group Ltd. | 62,665 16.600% | 62,665 (New Position) | Filing History |
| 2022-10-07 07:45 am Sale | 2022-10-04 | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 10,824 3.440% | -11,650 (-51.84%) | Filing History |
| 2022-09-22 4:15 pm Sale | 2022-09-21 | 13D | CATALYST BIOSCIENCES INC N CBIO | JEC II Associates, LLC | 0 0.000% | -25,050 (Position Closed) | Filing History |
| 2022-08-19 4:30 pm Unchanged | 2022-08-18 | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 22,474 7.100% | 0 (Unchanged) | Filing History |
| 2022-08-03 4:17 pm Unchanged | 2022-08-03 | 13D | CATALYST BIOSCIENCES INC N CBIO | SINGER JULIAN D. | 22,474 7.100% | 0 (Unchanged) | Filing History |
| 2022-08-01 4:15 pm Unchanged | 2022-07-31 | 13D | CATALYST BIOSCIENCES INC N CBIO | JEC II Associates, LLC | 25,050 8.000% | 0 (Unchanged) | Filing History |